Final Candidate Nominations List2019-11-02T08:20:13+00:00

Final Candidate Nomination list

(Candidates listed Alphabetically within Positions)

Position – President


Dafalla O Abuidris Elmustaf

Graduated in university of Gezira, Faculty of Medicine 1993. Worked as a general practitioner in Sudan for 7 years. Post graduate MD Radiation Oncology in South Africa College of Medicine 2004. Back to Sudan as faculty member in the national cancer institute, University of Gezira. Dean National cancer institute 2011 up to 2014. Full
professor 2015. Many publications in local regional and international reviewed journals. Organizer for regional training courses in oncology.

Many oral and poster presentation at regional and international conferences. Director General of the National oncology center, Federal ministry of health since 2017 up to now. Drafting national cancer strategy for Sudan. Vice President for Oncology postgraduate program in Sudan. Training of students at undergraduate and postgraduate level since 2004 up to now. External examiner for post graduate studies students in Sudan and Libya. Counterpart and coordinator for many International Atomic Energy Agency projects in Sudan. Advocate for cancer early detection programs in Sudan.

Membership of AORTIC since 2007. Membership in ESMO; ASCO AND AACR

Self-Assessment report:

Since I was born in this field of oncology in 1997, I spare no time in promoting and developing this field in my country in Sudan, in year 1999 we opened the second cancer center in Sudan when I was acting as executive manager for that project. I left to south Africa for my postgraduate studies and I am back as soon as I pass my final exam to continue my journey against cancer in Sudan. We introduce tumor board practice in our clinic since 2004. We made initiatives in early detection through raising awareness and get community to participate in such activities. I join AORTIC IN 2007 and since then my dream is to see it like its sisters’ organizations in another continent. I believe in African, in spite of our behind seat in cancer prevention and control to make the change to better development and care for cancer in Africa. I have special interest in having our own African experience in cancer research and treatment through inhouse collaborative research. Am not encouraging single institute research but always believe in working together with whatever fund gained. AORTIC need to help in setting models for small radiotherapy facilities constructional design and staff capacity building. A model for national cancer strategy draft should be prepared by AORTIC to help countries in this vital issue. Since treatment accessibility comes before early detection we must support and encourage countries which does not possess this service. I believe African Union should be approached in order to make support to this African organization which will help all of State members in their fight against cancer. African own guidelines for different cancer sites is important to tailor treatment according to our special constrains. Prevention programs need prioritization to tackle the most common, preventable and costless sites of cancer. We encourage collaboration between African states and other states outside Africa in different fields of cancer research and management. We need to approach different institutes and organizations to contribute towards AORTIC mission in Africa.

MD, FMCR, FICSAbubakar M Bello

Dr Bello Abubakar, MD is the immediate past Head of the Department of Radiotherapy and Oncology at the National Hospital Abuja in Nigeria, where he has served as a clinical oncology consultant and radiation oncologist for almost 15 years.

Dr Bello earned his medical degree from the Medical University of Varna in Bulgaria. He completed his training at the National Postgraduate Medical College of Nigeria in the faculty of Radiology, focusing in radiotherapy and Clinical Oncology. He is board certified in Clinical Oncology and Radiation oncology.

Dr Bello has special interest in Breast, Prostate, and Colorectal Cancers, and AIDS-related malignancies. He has special expertise in chemotherapy, targeted therapies, and immunotherapies. He also specializes in radiotherapy using the most advanced treatment planning systems, such as Monaco and Eclipse for conformal radiotherapy such as IMRT, IGRT and volumetric modulated arc therapy (VMAT) and many more.

Additionally, Dr Bello is an experienced administrator. In his past roles, Dr Bello utilizes keen analysis and a teambased approach to drive organizational improvements and implementation of best clinical practices. He has been an AORTIC member since 2008. He is a member of the African Cancer Coalition and has contributed to the
development of the NCCN Harmonized Guidelines for Sub-Saharan Africa for Prostate, Colon, Rectal, Anal Cancers as well as many other cancers.

Self-Assessment report:

I am a dynamic, versatile and result oriented leader with a strong track record of performance in the management and treatment of all types of cancers. As a team player, I lead by example and always happy to delegate authorities.

I single handedly conceptualize the Project “AIDS Malignancy Project”. We treated over 100 AIDS related cancers, in National Hospital, and they included cervical cancers, Kaposi’s Sarcoma, anal cancers and even breast cancer in HIV patients from a grant that was over $1.5 million. We also built a laboratory that is able to do resistance testing and Genotyping for HIV patients. The facility was the 1st in Nigeria and able to do the resistance testing even when the viral load is less than 1000.

As a head of Department of Oncology and Radiotherapy at the National Hospital, Abuja, Nigeria, I spearheaded the creating of a “New Radiotherapy Centre”. This was to be the only functional radiotherapy center in the country at the time. It also became the 1st center to have a CT simulator, a Monaco treatment planning system and a dual energy Linear accelerator, with 80 leaves multi-leaf collimator. This is as a result of teamwork and perseverance from all of us.

Again, as a member of the African Cancer Coalition, we were able to Harmonized NCCN treatment guidelines for at least over 85% of the cancers in Sub Saharan Africa.

Part of my challenges are getting like minds that understand the dynamics of cancer care in sub Saharan Africa. Professionals who are ready to go the extra miles to train Cancer Specialist in screening, diagnostics and treatment of cancers. We also need to provide infrastructures for early detection and early treatment. This will go a long way in reducing the incidents of late presentation of our patients.

Olufemi John Ogunbiyi
Department of Pathology, University College Hospital, Ibadan, Nigeria
Specialization: Anatomical and Surgical Pathology.
Interested in diversity of disease occurrence, pathology training and service, development of health plans.
Training: Graduated MBBS University of Lagos Nigeria 1983; FWACP (Lab Med.) 1990.
Postdoctoral Research Training Fellow of the International Agency for Research on Cancer (I.A.R.C.), W.H.O. Lyon, France, 1992.
Professor of Pathology, College of Medicine, University of Ibadan and Consultant Pathologist to the University College Hospital Ibadan, NIGERIA since December 1990.
Director, Ibadan Cancer Registry, a population-based cancer registry in operation since 1960.
Formerly Head Department of Pathology at Ibadan, Visiting Professor College of Medicine and Allied Health Sciences, Freetown, Sierra-Leone, 2003 and 2005, Professor and Academic Head, Kwame Nkrumah University of Science and Technology Kumasi, GHANA (2006-2007), Visiting Professor, Sultan Qaboos University Muscat, OMAN (2008).

An active Fellow of the West African College of Physicians, have served as its Secretary General. Member, Expert committee of the West African Health organisation for the harmonisation of equivalences of medical postgraduate training programmes in the Francophone West African countries. Foundation President of the West African Division of the International Academy of Pathology October 2006. Serve both the National Universities Commission and the Nigerian Medical and Dental Council as resource person for accreditation panels. Published several conference abstracts, Monographs, Chapters in Books and over 90 articles in peer-reviewed journals. AORTIC member since 2007.

Self-Assessment report:

Professional Objectives
I have practiced Anatomical and Surgical pathology as a specialist since 1990 within an academic hospital setting. I teach undergraduate students and postgraduate doctors and am involved in setting their training curricular.

My major interest is in the diversity of chronic disease, especially Cancer. In the cancer realm I set out to improve availability of diagnostic structure including personnel and have trained several specialist pathologists along with colleagues, facilitating the development of interest in diverse areas. I have developed research themes and mentored residents to produce fellowship dissertations. In the process we have been able to expand specialty areas of practice within our department.

To provide understanding of burden of disease, I started directing the Ibadan Cancer Registry in 2004 and have been able to increase case recruitment with more complete ascertainment, published two Cancer Registry Reports and just at the point of publishing our third edition.

I was the inaugural president of the West African Division of the International Academy of Pathology.

In AORTIC, I have served and pursued the organization’s objectives in various ways being a two-time V.P. for W/Africa, Co-chair and Chair of the Research Committee, an active participant in the Pathology Interest Group, and the President’s interim first chair of the Finance committee.

I have helped increase membership in West Africa significantly and represented the Organisation at international workshops and conferences.

I have participated in writing official documents including AORTIC’s Mission, Goals and Core Values, the State of Oncology in Africa, and the new document Cancer Control Status in Africa. I helped revise the National Cancer Control Plan for Nigeria and am on its implementation Committee.

My major challenge has been funding to support research ideas within the research committee because of the recent dearth of funding especially at the NCI/NIH group.

Position – President Elect


Rose Ihuoma Anorlu MBChB, FMCOG, FRCOG, FWACS, MPH, has been working in Nigeria throughout her career in Obstetrics and Gynaecology. She is currently a Professor of Obstetrics and Gynaecology, University of Lagos and a Consultant Obstetrician and Gynaecologist, Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. She was the head of Department of Obstetrics & Gynaecology of the two institutions (2015-2018) and heads the Oncology and Pathological Studies Unit.

She had her MBChB from University of Ghana and MPH from University of Lagos and her postgraduate training in obstetrics and gynaecology at the Lagos University Teaching Hospital, Lagos, Nigeria, and the Birmingham Maternity Hospital/ Birmingham and Midlands Hospital for Women, UK.

She was appointed Lecturer I in Obstetrics and Gynaecology in University of Lagos in 1994 and has been active in teaching, research and service delivery since then. She has many publications on cervical cancer prevention, her area of interest, in peer reviewed journals and chapters in textbooks. She has supervised to date about 24 dissertations for fellowship examinations of the Nigeria Postgraduate Medical College and West African College of Surgeons. She is an examiner for these two colleges.

She is a life member of AORTIC

Self-Assessment report:

Rose Ihuoma Anorlu is a Professor of Obstetrics & Gynaecology, University of Lagos and a Consultant Gynaecological Oncologist, Lagos University Teaching Hospital, Lagos, Nigeria. She heads the Oncology and Pathological Studies Unit of the Department of Obstetrics & Gynaecology. She was the Head of Department of Obstetrics & Gynaecology, University of Lagos/Lagos University Teaching Hospital from 2015 – 2018.

Rose Anorlu has been active in research, teaching and training medical students and resident doctors since 1994. Her main research area is in cervical cancer prevention and treatment. She has many publications in the area and has presented many scientific papers on the subject at local and international conferences. She had been an invited speaker at IGCS, AORTIC, SOGON, IPVC and GPSF conferences.

Besides her academic and clinical work, she also does a lot of community work and is also involved in national assignments. In 2006 she helped to set up a cervical cancer screening unit in a Primary Health Centre, in a in poorly served area of Lagos, Nigeria. She has trained many health workers in Lagos and other parts of Nigeria in cervical cancer prevention. She trained some of the few of the gynaecologists in Nigeria whose area of interest is gynaecological oncology.

She is a life member of AORTIC and has attended all the conferences of the organization since 2003. Anorlu was the Vice-President, West Africa sub region, Africa Organization for Research and Training in Cancer (2007-2009) and Council Member of International Gynaecological Cancer Society for Africa, Europe and the Middle East (2010-2014). She is the co-ordinator of National Cancer Control Programme in South-West Nigeria from 2013 till date. She was a member of the Committee that drafted National Cancer Control Plan 2018 – 2022. Currently she is a member of National Cancer Control Plan Implementation Committee.

Position – VP Central Africa


Achille Aurèle Mbassi
Mbassi Achille Aurèle holds a MD and a CES in Urology, Kursk State Medical University, Russia (1999, 2001) and a General and Endoscopic Urology Certificate (2010), SIU Training Center, Institute of Urology, KCMC, Moshi Tanzania.

From 2004 – 2009, he was a consultant, head of Surgery Unit at the Regional Hospital Maroua. From 2008-2009 he taught at the Nurse Training School Maroua. Since 2011 till today, he is a consultant at Yaounde Central Hospital. In January 2012, he was temporary teacher at the FMBS, University of Yaounde. He is a teacher at the Schools of Medicine of ISTM Yaounde, and of UDM Bangante and participates in the training of residents of surgery.

He is member of the Cameroon Medical Council, member and associate-treasurer of the Cameroon Urology Society, member and former Central Africa representative of the Pan-African Urological Surgeons Association (2013-2019), International Volunteer in Urology, member of the AORTIC and VP Central Africa (2017-2019), international member of the AUA, active member of the Société Internationale d’Urologie and current National Society Deputy Delegate of Cameroon in the SIU.

He is specialist in reconstructive urology and expert in male circumcision. He did many international lectures, wrote scientific papers and co-authored many publications.

Self-Assessment report:

Professional objectives
My goals are:
To reduce the mortality and morbidity of urological cancers in our poor environment, by improving the skills of our health personnel in screening.
Sensitizing our population on risks factors, and sensitizing medical staff and state-holders the more in taking part in this fight against cancers; and in doing so, to join AORTIC. This requires constant mobilization of state-holders and opening of local rural centers.
As a specialist interested in male external genitalia, I have noticed a recrudescence of cancers of the penis in a region of our country Cameroon. This calls for more investigation and we believe that advised circumcision is beneficial.

As VP AORTIC in Central Africa, we managed to organize a workshop in DR Congo in September 2018 on AORTIC plan for cancer control in Africa during the First Urological Days in Central Africa wherein more than five countries where represented, not counting those of the sub-region.
We likewise organized with the support of AORTIC a workshop during the First National Days of Cancer Imaging in May 2019 in Cameroon.
At a personal level, my position in AORTIC has increased the interest of my students and residents on cancers and its management.

It’s a constant challenge for us to provide quality care in our poor environment where most cancer cases are late stages. We are challenged by the need for sensitization in order to rule out avoidable risk factors from our population’s habits. We also need more health staff to find interest in this domain which most of times may seem unfruitful.

Position – VP East Africa


Consultant Breast Surgical Oncologist and Assistant Professor at the Aga Khan University, Nairobi (AKU)
Consultant Breast Surgical Oncologist and Assistant Professor at the Aga Khan University, Nairobi (AKU)Miriam Mutebi
Dr Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor at the Aga Khan University, Nairobi (AKU). She did her general surgery residency at AKU. She subsequently did a two-year fellowship in Breast Surgical Oncology, which included a year in plastics and reconstruction at the University of Cape Town, Groote Schuur Hospital in South Africa.

She then held a 2 year appointment as a Surgical Oncology Research Fellow at the Memorial Sloan Kettering Cancer Centre, New York. As a cancer surgeon, she has a keen research interest in understanding the barriers to the diagnosis and treatment, for women with cancers in Africa. She completed a Master’s degree in Clinical Epidemiology and Health Systems Research at the Weill Cornell University, New York and her focus lies in designing interventions to mitigate these barriers.

She has led projects training health workers in in breast health awareness and trains cancer advocates in both Kenya and South Africa.

She is the new African Regional Lead for the UICC and a member of the research committee of AORTIC. She is also the co-founder of the Pan African Women’s Association of Surgeons that aims to provide mentorship for women in surgery and to improve women’s health and surgical care on the continent.

Self-Assessment report:

I am a breast surgical oncologist working in East Africa. In my practice, many patients are diagnosed with advanced cancers and frequently do not complete their treatment. As a clinical epidemiologist and health systems researcher, my focus has been on understanding barriers to care for women who have cancers in Africa and in designing interventions that address and mitigate these barriers. This calls for innovative strategies to improve cancer detection and care in our setting.

One fundamental tenet is that low resources should not equate to suboptimal care and it is to this end that I conceptualized, and with a great team, successfully run the first international breast cancer symposium in the region bringing together local, regional and international multi-disciplinary experts to work together to effect best practice in East Africa. There has also been a paucity of good breast surgical oncology skills, so my second aim has been to provide training for surgical residents and surgeons to improve the quality of continental breast surgical care. It is to these end that I conceptualized, mobilized a team and developed the first International Breast Oncoplastic workshop in Africa bringing 23 professionals from 4 different continents with a collective aim to improving continental breast surgical services. Going forward, the plan is to scale up in order to disseminate this training to the region and continent.

My aim is to work with AORTIC to help build research and data driven communities of practice that improve women’s health and surgical oncology skills on the continent. This is a multi-layered concern which needs to address issues of health awareness, education, socio cultural and other barriers to early detection and treatment of disease but also needs to consider equity and empowerment of women. Key to this is developing health systems research that directly address patient concerns.

MBChB, MMed, MedOnc (UK), FCP (ECSA) Consultant Medical Oncologist & Lecturer University of Nairobi (UON)
MBChB, MMed, MedOnc (UK), FCP (ECSA) Consultant Medical Oncologist & Lecturer University of Nairobi (UON)Andrew Odhiambo
Dr. Andrew is the Deputy Program Director of the Medical Oncology Fellowship program at UON. He attended his Fellowship in Medical Oncology in the United Kingdom and received his certification from the Federation of Royal College of Physicians of the United Kingdom and the European Society for Medical Oncology.

He is the Secretary of Kenya Society of Haematology & Oncology (KESHO) and a member of ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees.

Dr Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 40 appearances in mainstream local TV and print media promoting cancer awareness. Key areas of sub-specialization and interest include Lymphoma, Breast Cancer, GI cancer, Sarcoma, Cancer or Unknown Primary, as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Lung, Kidney cancers etc. For his full profile, please visit

Self-Assessment report:

Professional Objectives

  • To provide mentorship to younger doctors in the field of Oncology including supervision of postgraduate dissertations.
  • To participate on on-going knowledge assessment in Medical Oncology and keep UpToDate.
  • To attend and present in local and international oncology conferences and meetings.
  • To publish at least 2 Oncology articles in peer reviewed journals.
  • To participate in policy work towards cancer control in the country.
  • To continue promoting cancer awareness.
  • To contribute to writing of cancer treatment guidelines.
  • Provide strategic leadership in matters oncology in Kenya and beyond.


  • Provided mentorship to young doctors and registrars who want to pursue oncology as a career.
  • Attended largest international lymphoma meeting in Lugano this year.
  • Presented in several local oncology seminars & meetings.
  • Co-supervised 3 internal medicine post graduated dissertations in oncology.
  • Contributed to NCCN harmonized treatment guidelines for Africa.
  • Appeared more than 20 times in local & international TV and print media promoting cancer awareness.
  • Sat the ASCO Medical Oncology ITE as deputy program directors and scored above average.
  • Contributed to development of Cancer Screening Guidelines for Kenya.
  • Current secretary of the Kenya society of Haematology & Oncology.


  • Workload pressure – too many undergraduate students, exams & teaching.
  • Inadequate funding and protected time for research.
  • Work-life balance (time dedicated to private practice).

Suggested areas of self improvement

  • Dedicate more time to research & collaboration including international collaboration.
  • Build portfolio with a view to promotion to senior lecturer.
  • Undertake training in grant writing for future oncology research.
Ph.D. (JOOUST), MD.(NBI), M.Med. (Int.Med)(NBI), FRCP (Edin), Gastroenterology (Tel-Aviv)
Ph.D. (JOOUST), MD.(NBI), M.Med. (Int.Med)(NBI), FRCP (Edin), Gastroenterology (Tel-Aviv)Amos E. O. Otedo
A consultant Physician and PhD (Public Health), trained in Internal Medicine, Gastroenterology/Hepatology, leadership and strategic management; with skills of over 28 years. Immediate former CEO, Kisumu County and Referral Hospital, for 5 years, overseeing daily operations (administrative, financial, strategy, research and human resource), and improved team work. He established diabetic, medical and liver clinics; created open days to promote dialogue between the staff and stake holders, improved health system strengthening (HSS), developed the hospital’s strategic Plan [2014-2018] and improved financial management and resource mobilization

Research in Malaria, HIV/AIDS and liver cancer, I am a W.H.O. appointed Consultant and I developed the National guidelines on management and control of viral hepatitis in Kenya, 2018. Developed 2 guidelines on Hepatitis Management. Published 23 papers:

Self-Assessment report:

A medical practitioner, PH.D Holder and trained in internal medicine, gastroenterology, leadership and strategy, currently Chief of department of internal medicine, gastroenterology/hepatology.

I’m the immediate former CEO/medical superintendent, Kisumu county and referral hospital for 5 years and 7 months overseeing the daily operations (administrative, financial, strategy, research and human resource).


As the CEO, i chaired vital committees which include: Health Management Team, Health Management Committee, Executive Expenditure (Finance) Committee and I managed an annual hospital budget of US $ 800,000, Medicines and Therapeutics Committee, Universal Healthcare Committee.

Improved emergency services, partnership between the hospital and stake holders.

Improved health system strengthening (HSS) by establishing weekly diabetic, medical and liver clinics, I developed the hospital’s Strategic Plan [2014-2018], Improved financial management and resource mobilization;

I do research malaria vaccine and drug trials (medical monitor), liver cancer and HIV/AIDS, a W.H.O. appointed Consultant and I developed the National guidelines on management and control of viral hepatitis in Kenya, 2018. I have both national and international professional affiliations
I have published 22 papers: publication titles see:

Finally, therefore, I possess the following skills and competencies: Technical, Administrative and financial, forward planning and Strategy, critical thinking and positive interpersonal skills.

Primary Objectives:

  1. To offer timely, quality specialist health services and operations research
  2. Improve health systems strengthening in the hospital and the county of Kisumu
  3. Improve hospital’s infrastructure for better service delivery, training and revenue generation
  4. Improve governance in the hospital.


  1. Shortage of human resource due to brain drain and poor remuneration
  2. Lack of commitment by the policy makers and political leadership to support health
  3. Lack of funds
  4. Stress to the healthcare workers who are overworked

Lack of equipment and appropriate infrastructure for better health service delivery

Position – VP North Africa


MD, PhDAhmed Elzawawy
Professor Ahmed Elzawawy: Locally in Egypt he is an Emeritus Professor of Clinical Oncology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt, Supervisor and Senior consultant of Medical Oncology and Radiation Oncology departments, Ismailia Cancer teaching Hospital, and Chairman of Alsoliman Clinical and Radiation Oncology Centre, Port Said, Egypt. Regionally and internationally: Last Post in AORTIC was Past President of AORTIC. At Present Prof. Ahmed Elzawawy is the Chair of Harvard Global Health Catalyst Win-Win scientific initiative (a Global Scientific initiative that aims at the increase of affordability of better value cancer treatment in the world starting from Africa), Chair of Board of Directors, Global Oncology University, President of ICEDOC (ICEDOC: International Campaign for Establishment and Development of Oncology Centres. An Editorial Board Member of Journal of Global Oncology, issued by ASCO, and ecancermedicalsciences, World Journal of Surgical Oncology, International Advisory Board Member in Lancet Oncology, Member in ASCO’s resource stratified advisory group (ASCO: American Society of Clinical Oncology), Editorial Board Member of Journal of Global Oncology, issued by ASCO and Member of ESMO Global Policy Committee (ESMO: European Society of Medical Oncology).

Position – VP Southern Africa


Radiation - Oncologist registered with HPCSA, Head of Clinical Unit University of Cape Town and Groote Schuur Hospital
Radiation - Oncologist registered with HPCSA, Head of Clinical Unit University of Cape Town and Groote Schuur HospitalZainab Mohamed
Academic Qualifications: 2004 MMed (Radiation Oncology) University of Stellenbosch; 1992 MBCHB University of Cape Town Work.
Experience: 2017 to date Head of Clinical Unit UCT/GSH 2005-date Consultant Radiation Oncologist in charge of Lymphoma and Kaposi’s Sarcoma clinics UCT/GSH 2004-2005; Research Fellow iThemba LABS, Cape Town 2000-2004; Registrar Radiation Oncology, Tygerberg Hospital Teaching 2005; Registrar teaching and clinical training 2005-date; Undergraduate teaching 2015-date; Examiner for the College of Medicine of South Africa Radiation Oncology part 1 and 2 examinations 2012-date; Supervised 2 completed registrar commentaries, 1 completed MMed and currently supervising 3 MMeds and 1 Masters student 2017-date; Access to Care course: Lectures on Consent and Survivorship 2019; Convenor of the UCT Palliative Care Training for Oncologists course Research 2009-date; Coauthor of 9 peer-reviewed publications 2012-date; PI in 4 international clinical trials: 3 lymphoma, 1 breast 2017; Presented 2 posters at AORTIC Other 2017-date; Member of UCT Human Research Ethics Committee 2010-date; Coordinator of the GSH Oncology outreach program to George Hospital; Member of SASCRO, ESMO and AORTIC

Self-Assessment report:

I am a Radiation Oncologist working at Groote Schuur Hospital and the University of Cape Town for the past 14 years. In March 2017 I was appointed Head of the Clinical Unit. My role encompasses the clinical, administrative, educational and research spheres.

We form part of a large teaching hospital and our department sees more than 3000 new cancer patients per year. We train 16-18 residents at any given time (8 local and 8-10 international students). We primarily provide a clinical service to our community and are fortunate that we can offer good care to all regardless of means. We are constrained by the lack of some chemotherapeutic and biological agents but have developed local treatment protocols that take these budgetary constraints into account. We have a world-class radiotherapy service with very short waiting lists. Staffing issues, theatre time and access to Radiology is still a challenge. Our goal is to continue delivering a good quality service and to ensure that we produce Radiation Oncologists who are not only skilled in the technical aspects of Clinical and Radiation Oncology, but are also academically strong, able to become leaders in their fields and, most importantly, are good kind doctors able to work well in a team.

Research is an integral part of our work; however, our large clinical load adversely affects the amount of research we can produce. AORTIC gives the African Oncologist the forum to pool knowledge, improve capacity and produce useful research for local conditions. I am saddened by the unequal access to care and needless suffering that patients with cancer and their families experience daily in Africa. My goal is to collaborate with like-minded individuals to promote good preventative, curative and palliative cancer care throughout Africa through partnership and research.

Position – VP West Africa


Psycho-oncologist, Professor and Head of Department of Guidance and Counselling at the University of Ibadan in Nigeria.
Psycho-oncologist, Professor and Head of Department of Guidance and Counselling at the University of Ibadan in Nigeria.Chioma Asuzu
I am a psycho-oncologist, professor and Head of Department of Guidance and Counselling at the University of Ibadan in Nigeria. I hold joint appointment with the Department of Radiation Oncology at the College of Medicine of the University of Ibadan and its affiliate University College Hospital (UCH) in Ibadan. I am also specialist adviser to the University College Hospital on psycho-oncology. I completed fellowships of cancer prevention and control of NCI and UICC.

I have dedicated my career to spread the practice of psycho-oncology in Nigerian and Africa via research, clinical practice, advocacy and education. My research has spanned many areas of psycho-oncology. My current research explores the role and problems associated with seeking care from alternative healers in the delivery of cancer care in Nigeria so as to improve on the early presentation of the patients.

I am the Foundation President of both the Psycho-Oncology Society of Nigeria (POSON) and the Association for Psycho-Oncology in Africa (APOA) as well as an executive member of IPOS as board member of the International Psycho-Oncology Society (IPOS). I have been an active member of the research committee of AORTIC and I am the current vice-president of AORTIC for West Africa.

My membership of the AORTIC Council would continue to provide a beneficial platform to expand psycho-oncology in all of Africa especially in the building of multidisciplinary teams for the practice psycho-oncology in the region.

Self-Assessment report:

I am clinical psychologist, focusing my research and clinical practice in the area of psycho-oncology where cancer patients are psychologically managed, clinical research is carried out and community services given in form of seminars and workshops in the area of cancer prevention and control. I have contributed immensely to the development of psycho-oncology in Nigeria and Africa. I have mentored a lot of individuals across Africa in this area and, in my home university, led the development of a Masters programme in psycho-oncology.

My objective is the creation of awareness, knowledge and practice in the area of psycho-oncology as well as the inclusion of distress assessment as the 6th vital sign for all the cancer patients on the African continent. Also, to continue to lead the development of psychotherapeutic tools for management of distress and enhancement of quality of lives of cancer patients.

In my last term as Vice President for West Africa, I presented a lecture during the West African College of Surgeons in Banjul in the Gambia in 2018 on psycho-oncology. I similarly presented a paper on psycho-oncology during the URODAK (West African Urological) conference in Dakar, Senegal in April 2018. These events helped to spread the practice of psycho-oncology across Africa, resulting in a larger membership of the Association for Psycho-Oncology in Africa by 20%. Also, as a part of APOA, we have organized three Psycho-Oncology academies in Rwanda, Nairobi and Mobutu with psycho-oncologists from across the world giving lectures which some oncologists have benefited from. All these activities were used to enhance the membership of AORTIC.

If elected to another term, my plan is to continue to expand the psycho-oncology practice on the continent by promoting multidisciplinary research with academics participating from across Africa. Psychologists should work together with researchers in the medical community to discover best practices from countries across the continent.

OncologistHirondina Vaz Borges Spencer
Hirondina Vaz Borges Spencer, Oncologist, graduated in Medicine from the University of Havana Cuba in 2000, worked as a general practitioner for several years – Health Delegate of Boa Vista Island.
Specialist in Oncology by the National Institute of Oncology and Radiobiology in Havana.
Oncology Service Director, Agostinho Neto Hospital, Cape Verde
Member of the Board of Directors of Agostinho Neto Hospital
Member of the Cape Verde Order of Physicians and was a member of the National Board of the Order of Doctors for several years.
Member of AORTIC. Organizer of the first congress on cancer in Cape Verde and the third congress of AORTIC PALOP in Cape Verde and organizer of several courses in cancer in Cape Verde.

Participated as a trainer in courses on breast cancer, gastric cancer, palliative care and pain, oesophageal cancer, cytotoxic manipulation courses.
Participated in the elaboration of a national guide against cancer.
She has participated in several national and international cancer courses and congresses as a speaker.

Self-Assessment report:

Cancer in Africa and Cape Verde is a major public health problem and we health professionals working in this area in Africa face a great challenge of doing very, with littie resources, thanks to selfless delivery, with humanism and empathy we can work with them. conditions for cancer equipment, infrastructure and medicines.
 I am a medical oncologist for several years, I am the first oncologist in Cape Verde, I dedicate the cause of cancer with passion and empathy, my great challenge and responsibility was to organize cancer care in the country, and I still have many challenges ahead, due to the lack financial resources, infrastructure, and human resources to fight cancer, I have to work for partnerships, raise government awareness of cancer investment, improve cancer approach by setting up a cancer center the multidisciplinary approach to cancers, training human resources and focusing on cancer research.

Make more government investment to fight cancer
To make this area of ​​cancer attractive to young people to continue the work, to focus on a multidisciplinary team approach and the creation of therapeutic protocols, to focus on the continuing education of professionals.

Encourage and sensitize the population to lifestyle changes and active participation in the fight against cancers.

Consultant Haematologist at the Obafemi Awolowo University (OAU) and OAU Teaching Hospitals, Ile-Ife, Nigeria
Consultant Haematologist at the Obafemi Awolowo University (OAU) and OAU Teaching Hospitals, Ile-Ife, NigeriaAnthony Oyekunle
Dr. Oyekunle is a Reader and Consultant Haematologist at the Obafemi Awolowo University (OAU) and OAU Teaching Hospitals, Ile-Ife, Nigeria. He was also until recently an Associate Professor and Consultant Haematologist at the University of Botswana and the Princess Marina Hospital, Gaborone, Botswana.

He obtained an MBBS degree from the University of Ibadan, and completed a Haematology residency in 2006, and fellowships in Haematopoietic Stem Cell Transplantation, Chronic Myeloid Leukaemia, and Molecular Diagnostics in Germany, Italy and the USA respectively. Dr. Oyekunle’s research has focused on haemato-oncology and haematopoietic stem cell transplantation (HSCT), out of which has emanated over 40 peer-reviewed papers. He is widely regarded as an African leukaemia expert and patient advocate.

Most recently, he is collaborating with researchers in Botswana, in Europe and the United States, to study chronic myeloid leukaemias in Africans and also advocating for improved access to the best treatment options for underresourced communities. His other research interests are in the areas of molecular diagnostics and cytogenetics. Dr. Oyekunle is one of the pioneering members of the Nigerian Group for Blood and Marrow Transplantation, is a certified JACIE Inspector for clinical HSCT programs, and sits on the Editorial Board of the Leukaemia Research journal.

Self-Assessment report:

My work is focused on haemato-oncology and stem cell transplantation (SCT). My first major research paper helped establish the relevance of SCT in the management of refractory acute leukemia. More recently, I have worked on the role of tyrosine kinase inhibitors (TKI) in the management of several malignancies including chronic myeloid leukemia; including the relevance and safety of TKIs among Nigerians and Motswana.

I have initiated or participated in several collaborative research activities, working with experts in Europe and the United States. In the course of my work, I have received several competitive travel awards and research grants. Additionally, my work has resulted in numerous fellowships including the ERSAP fellowship of the International Chronic Myeloid Leukaemia Foundation, the ICRETT fellowship by the Union for International Cancer Control, the Global Health Fellowship of the University of Chicago Medical Center, Chicago, USA. These opportunities equipped me to be able to contribute to the setting up of a Molecular Diagnostic laboratory unit in Ile-Ife.

I am passionate about the sustainable management of cancers in the African continent, and I am regularly involved in the organization and delivery of postgraduate-level courses to younger colleagues, and contributing to the training and mentoring of resident doctors in Hematology and other medical sub-specialties.

Some of the enduring challenges remain the inequalities in anti-cancer drug research, development and access between the developed and the developing countries, as well as the absence of universal health coverage in most African countries, especially one that caters for cancer patients. It is therefore imperative that medical leaders in Africa should recognize the urgent need renewed advocacy for changes in critical healthcare legislations to move oncology practice in Africa to a higher pedestal.

Position – VP Nursing


Assistant Professor of Nursing & Coordinator of Oncology Nursing Specialty (Institute of Nursing, NCI, Cairo University)
Assistant Professor of Nursing & Coordinator of Oncology Nursing Specialty (Institute of Nursing, NCI, Cairo University)Nagwa Mohamed Elkateb
Coordinator of the Oncology Nursing Specialty Diploma, NCI, Cairo University, Member, planning committee, Nursing Education Sector, Supreme Council of Universities, Egypt. Director, Oncology Nursing Institute, NCI, Cairo University (1996-2009).

Certificates – 1980-2013: Certificate, Palliative care advanced course, ONS, Certificate, ELNEC (End of Life nursing education consortium), USA. Certificate, EPIC- O (Education in palliative care and end of life care- oncology). ASCO & NCI, Virginia, USA. Certificate, BREAST CANCER – TRAIN THE TRAINER Program, ISNCC, Singapore. Certificate, Oncology nursing course, ONS&UICC, Egypt. Certificate, Early detection & prevention of Cancer and teaching Breast Self-Examination, M.D Anderson Cancer Centre, Post basic certificate in Cancer Nursing. Royal Marsden Hospital, UK.

Professional Activities – 1979-2011: Organizer, Pressure Ulcer & Entrostomal therapy Workshops for Middle East, Gulf region &North Africa nurses. INCTR-Cairo Cancer Nursing workshop, UICC-Cairo two Cancer Nursing Courses, Coordinator, Chemotherapy training program for nurses from Sudan. Coordinator, Radiotherapy training program for Yemen nurses, NCI, Cairo in collaboration with IAEA, Coordinator of nursing collaboration project, NCI Cairo University & KHCC, Amman, Jordan. Director, Nursing Team, Palliative care program, NCI, Cairo (2008-2010). Organizer and Head of Faculty members of the first UICC Course on Cancer Nursing. Cairo, Egypt. Member of the steering committee for palliative care, Middle East Cancer Consortium (Egypt Representative from 2005-2009). Member of Nursing committee “preparation of radiotherapy nurses training v syllabus “, & presenter of first draft, International atomic energy agency, Vienna, 2005. Short term WHO Consultant for Nursing development, Iran 1994. Member of the Egyptian Bone Marrow Transplant Team in Soliman El Fakih Hospital, Saudi Arabia 1990. Member of the UICC Nursing Education Committee (1983-1986).

Self-Assessment report:


  • Organize a committee including a nurse representatives from each region in Africa to facilitate communication with and through different centers as well as dissemination of relevant information.
  • Encourage Nurse professionals to join the AORTIC.
  • Establish an AORTIC Nursing chapter for different regions
  • Collaborate with cancer nurses in the field of training, education and research
  • Develop cancer nursing guidelines and cancer care standards
  • Propose for a regional accreditation committee to guide, advise, support cancer nursing programs
  • Organize cancer nursing workshop held yearly in one of the regions to enhance the quality of cancer patients care
MGCNM(ONC), MPH, BSN, OCN, FWACNNaomi Oyoe Ohene Oti
Naomi Oyoe Ohene Oti is the Registry Manager of the Accra Cancer Registry and Advance Oncology Nurse Specialist at the National Radiotherapy Oncology Centre, Korle-Bu, Ghana. Has over 17 years’ experience in the field of oncology. She holds Post Graduate membership in Oncology Nursing, Master’s in Public Health, first degree in Nursing and Psychology, with a certificate in Oncology Nursing. She is a Cancer Nursing Policy Leadership Scholar. Naomi has been the Clinical Trial Coordinator for her facility for the past thirteen years. She is a curriculum writer and the focal person for Oncology Nursing for Ghana in the IAEA/VVUCCnet Program. In 2016, she received the Prestigious International Society of Nurses in Cancer Care (ISNCC) Past President’s Award in recognition for initiating and sustaining Oncology Nursing training in her facility and Ghana as a whole. Naomi is a member of several societies such as AORTIC, ESMO, ONS, ISNCC and been a resource speaker in many of such conferences. She has a number of published papers to her credit. She is currently the Vice President Nursing for AORTIC and one of her interest is advocating for oncology nursing to be recognized as a specialty in Africa.

Self-Assessment report:

My main professional goal is to be an expert and a researcher in the field of Oncology. I have been vital in oncology nursing education at my facility and in Ghana. In 2002, I had training at Mayo Clinic in the USA in the coordination of clinical trials and this program inspired me to pursue formal training in oncology. I used my training to institute a variety of in-house training programs that have enabled nurses to deliver quality cancer care. I was also able to convince management of my department to help train 6 nurses through the oncology distance education program with the Cross Cancer Institute, Alberta Canada. In 2012 was also chosen to be the focal person for oncology nursing training at the VUCCnet (Virtual University of Cancer Care Network, an IAEA Initiative) for Ghana’s Ministry of Health.

In 2014 /2015, I was among a team of specialists who developed the Postgraduate Clinical Oncology Nurse Specialist curriculum for the Ghana College of Nurses and Midwives and was one of the first cohort to graduate in 2018. I was also a recipient of an ISNCC conference scholarship to 13th ICCN 2004 in Sydney, Australia and a fellow of West African College of Nursing.

One of my goals is to always challenge myself to learn and master new skills. In 2017, I became the Vice President, Nursing for AORTIC. For the first time have been able to rally nurse leaders from 11 countries to help develop competencies for oncology nursing education and training in Africa. This would help to harmonise and standardize training of oncology nurses in Africa. In 2019, I had training in Geneva by the ICN/ISNCC to become a Nursing Policy Leadership scholar.

One of my challenges has been not able to bridge the gap between academia and practice.

Position – VP Europe


MBE MBBS MS MML (Med Law) FRCS (Eng) FRCS(Ed) FRCS (Urol) FEBUFrank Chinegwundoh
Professor Chinegwundoh is a Consultant Urological Surgeon at Barts Health NHS Trust, in London, UK and honorary visiting Professor to the School of Health Sciences, City, University of London. He is an academic clinician. He has a particular interest in ethnicity & prostate cancer. He published the first paper in the UK demonstrating a 2-3 fold
increase risk of prostate cancer in black men. In November 2016 he was the subject of a BBC news piece on prostate cancer research in the UK and Nigeria.

He has a longstanding interest in cancer in general through his 21 years chairmanship of the UK registered patient charity Cancer Black Care. He has been a government advisor on cancer since 2007. He has co-chaired the Prostate Cancer Advisory Group and is a member of the Bowel Screening Advisory Committee. In 2013 he was awarded an MBE (a national award) for services to the UK National Health Service.

He has contributed to several AORTIC meetings as a presenter. In the UK he is a member of the Medical Association of Nigerians across Great Britain. He has sought to foster closer ties with AORTIC.

He is the current VP Europe AORTIC.

Self-Assessment report:

  • I have been an active AORTIC member since 2013.
  • I am research active, particularly in the area of prostate cancer.
  • I continue to chair a UK based charity – Cancer Black Care (since 1998).
  • I have been VP Europe for the past two years and seek re-election.
  • My attendance at Council meetings has been good. I will be contributing as a speaker at the Maputo AORTIC meeting in November 2019.
  • In my tenure I reached out to several European members.
  • I represented AORTIC as a speaker on the Harvard Global Health Catalyst meeting in 2018 held at Mannheim, Germany.
  • I have been instrumental in the upcoming meeting Canfomedics-AORTIC oncology meeting to be held in October 2019 in Essen, Germany.
  • I have sought to publicise AORTIC at every opportunity.
  • A challenge going forward is to increase the membership from Europe.
MD, PhDLuca Incrocci
Luca Incrocci is Professor of Genito-Urinary Radiotherapy at the Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands. He received his MD in 1992 at the University of Pisa, Italy, and then joined the University Hospital Rotterdam to complete residencies in the Departments of Urology and Radiation Oncology. His current research is focused on Quality of Life of cancer patients and on the development of radiation techniques to improve treatment outcome and to decrease side effects of radiation therapy for genito-urinary malignancies.

He is actively involved in international programs to provide education and improve radiation therapy access in African countries. He has been a member of the UICC’s Global Task Force on Radiotherapy for Cancer Control and an advisor for developing radiotherapy facilities and PhD programs in Ethiopia. He is part of the Win-Win initiative of the Harvard Global Health Catalyst, and he recently launched his foundation ( to improve cancer care in Ethiopia.

Prof. Incrocci is member of several scientific societies, he is actively involved in teaching and supervising fellows and PhD students and is author of more than 150 peer-reviewed papers, reviews, book chapters.

Self-Assessment report:

I am a Professor of Genito-Urinary Radiotherapy at the Erasmus Medical Center, Rotterdam, The Netherlands. In the last 8 years I have become involved in several international programs to provide education and improve radiation therapy access in African countries. My first AORTIC meeting was in Durban in 2013, and I was happy to meet so many people with the same interest to improve cancer care in Africa. AORTIC is doing a wonderful job, though I would like to see more focus on radiotherapy. Radiotherapy is such an important modality for cancer treatment and this is often not addressed when developing national cancer programs.

I am a member of the AORTIC Membership Committee, and I have been an invited speaker at the last 3 meetings. Within AORTIC I would like to help developing and coordinate cancer education and training activities, and encourage and organize multi-disciplinary approaches to cancer management. Furthermore I would like to organize at least 1 activity each year in Europe to raise awareness about AORTIC (not well known in Europe), and to help raising funds for educational activities in Africa.

I would also like to develop academic programs at several African universities, related to radiotherapy. I have a PhD student doing radiotherapy research in Ethiopia and I would like to expand this program to other African countries. AORTIC is an ideal network to develop this kind of programs. I have good relationship with the industry that can help in raising funds for research activities in Africa.
I have experience in running successful societies and international meetings, having served the executive committee of ISSM (International Society for Sexual Medicine), with 2300 members, for 14 years. Now that I finished my term as ISSM Past-President, I am committed to dedicate all my time to AORTIC as your VP for Europe.

B.SC., MB.CH.B. DMRT., FRCR.Gordon A Read
Gordon Read is Life Fellow of the Royal College of Radiologist and Oncologists, London UK, Life Fellow of the Royal Society of Medicine, London.

MB.CH.B 1966 Birmingham UK; 1966-1968 Internships: Harare Central Hospital, Zimbabwe; 1968 -76 Medical Officer Malawi, Chairman of Non -Governmental Hospitals, Authors of Obstetrics and Gynaecology in the Tropics; 1981-2016 – Consultant Radiation Oncologist UK; 2000-2012 – University Hospital of North Middlesex, London, 2012-2016 – Cancer Lead and Postgraduate Chairman for North London- Essex and Hertfordshire.

Self-Assessment report:


  • Promotion of collaborative care for cancer prevention, detection and treatment
  • Engagement of medical equipment industry to harness resources and overcome logistical barriers to improvements in oncology services
  • Avoidance of competition wherever and whenever possible
  • Fullest co-operation with ministries of health throughout the continent
  • Structuring of oncology training
  • Publication of postgraduate institutions willing to provide training
  • Standardisation of training
  • Equity of grants for trainees
  • Robust implementation of telemedicine, telepathology, teleradiology and teleradiotherapy planning
  • Identification and establishment of University partnerships with European oncology Institutes
  • Selection of Research projects by AORTIC council. Focus on achieving a balance between diagnostic, surgical, radiotherapeutic and systemic treatment investigation and trials
  • Involvement of WHO, IAEA, IARC (Epidemiological Centre of Excellence, in addition to it’s vast databases of global oncology information), ESTRO, ASTRO whenever and wherever possible.


  • 10 years of working in African Medical Institutions, University, Rural Practices
  • Organisation of National Seminar on Public Health Education in Malawi
  • Strategic planning of National Health Personnel for a projected 15 year period in collaboration with Malawian Ministry of Health
  • Emphasis on teaching, training and preventive measures
  • 8 years of surgical experience in Africa
  • 10 years of tropical medicine clinical work
  • Facilitation of grants and further post graduate experience of African Oncology trainees over the past three years
  • Development of close working relations with International experts in the fields of medical physics, telemedicine and cancer epidemiology
  • Concurrently close liaison with medical physics colleagues in Malawi
  • Support of Radiation Oncology Centre development
  • Lecturing in the UK on Global Oncology
  • Lecturing at a world congress
  • Meeting with IAEA in Vienna and hosting their visit to London
  • Continued collaboration with colleagues from France, Germany and Italy
  • Involved with Oncology Service in African Countries.

Position – VP North America


Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, Bronx, N.Y., USA
Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, Bronx, N.Y., USAPhilip Castle
Dr. Philip Castle is a Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, Bronx, N.Y., USA. He is a Visiting Professor at the National University Health System of Singapore. Previously, Dr. Castle was the Chief Scientific Officer of the American Society for Clinical Pathology (ASCP) (2011-2). He was a Senior, Tenured Investigator (2010-11) and Tenure-Track Investigator (2003-10) in the Division of Cancer Epidemiology and Genetics (DCEG) at the U.S. National Cancer Institute (NCI). He received his Ph.D. in Biophysics in 1995 and M.P.H. in Epidemiology in 2000 from the Johns Hopkins University.

Dr. Castle is currently conducting cancer screening and treatment research in Africa, Asia, Latin America, Europe, and North America. He was a member of the CDC National Breast and Cervical Cancer Early Detection and Prevention Advisory Committee, Steering Committee for ASCO’s Cervical Cancer Resource Stratified Secondary Prevention Guideline Panel, and WHO Strategic Advisory Committee on in Vitro Diagnostics (SAGE IVD). Dr. Castle currently is the Associate Chair of Cancer Prevention and Control for the AIDS Malignancy Consortium. He is a member of the WHO Guidelines Groups for 1) Thermoablation for Cervical Treatment and 2) Screening and Treatment to Prevent Cervical Cancer.

Self-Assessment report:

My goals in this position are to increase the opportunities for junior African scientists to conduct cutting-edge research in cancer biology and population research to improve the lives of Africans. This will be accomplished through increased, personalized mentorship of promising African scientists, as has been my experience in Rwanda, and developing new funding opportunities for them.

My professional interests are (1) epidemiology of human papillomaviruses (HPV) and cervical/anogenital cancer; (2) science and translation of cancer prevention strategies; (3) cancer screening; (4) international health; (5) health services research; and (6) evidence-based medicine. My main scientific contributions have been in the validation of HPV testing strategies for cervical and anal cancer screening, and the development of personalized, risk-based management for cervical abnormalities. Although the focus of my work has been primarily in HPV and anogenital cancer over the last 20 years, in the last couple of years my interests have broaden to include screening for oral, breast, lung, and colorectal cancer. The majority of my research is now conducted in low- and middle-income countries and focuses on developing/adapting and validate cancer prevention and control strategies and technologies that meet or exceed current standards-of-care while increasing accessibility.

For my work in cervical cancer prevention, I have received (1) An EUROGIN Distinguished Service Award (2006); (2) a NIH Merit Award for introduction of HPV testing into low-resource settings in the U.S. (2007); (3) a Distinguished Scientific Achievement Award from the ASCCP (2010), its highest honor; (4) The Arthur S. Flemming Award for Exceptional Achievement in Federal Government Service for Applied Science, Engineering and Mathematics (2010); and (5) NCI Cancer Prevention Fellowship Program Distinguished Alumni (2017-8).

MD Texas Tech University & residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology
MD Texas Tech University & residency training at Baylor College of Medicine in Internal Medicine and Radiation OncologyAnuja Jhingran
Dr. Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology. She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Centre in 1996 and has advanced to a Professor of Radiation Oncology in the Section of Gynaecology. She is a physician specializing in the treatment of gynaecologic cancers. Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity. In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG) in the development of patient care studies to treat gynaecologic cancers and is the national Principal Investigator of several accruing studies including a phase III study in cervical cancer. Dr. Jhingran travels extensively internationally for cancer education. She is passionate about women’s health issues and especially as it relates to developing country’s efforts to establish improved health care for the general populace, not just the financially able.
T. Peter Kingham
Dr T. Peter Kingham obtained his undergraduate degree at Yale and MD from SUNY Stony Brook. His surgery residency was at New York University. He undertook a two-year research fellowship in immunology at Memorial Sloan Kettering Cancer Centre (MSK) during residency. After residency, he completed a two-year fellowship in surgical oncology at MSK and was appointed on the Hepatopancreatobiliary Service.

He cofounded the NGO Surgeons OverSeas (SOS) in 2006. With SOS he performed clinical research in West Africa and collaborated on training. At MSK, he created the Global Cancer Disparity Initiatives program, and was appointed Director (2015). In 2016 he was promoted to Associate Professor. His research interest is determining how to improve cancer care for patients in sub-Saharan Africa, specifically Nigeria. Dr. Kingham is co-PI on multiple prospective oncology studies in Nigeria and cofounded the African Research Group for Oncology in 2013. He is PI of a UG3/UH3 NIH grant to study new technologies to diagnose cancer in Nigeria.

In addition, he has assisted with expanding liver and pancreas surgery in Nigeria. He has mentored over 15 physicians from sub-Saharan Africa with oncology-focused careers. He has over 160 publications in peer-reviewed journals and authored 11 chapters.

Self-Assessment report:

Since 2001, I have been collaborating with colleagues in sub-Saharan Africa on surgical oncology and general surgical research and training, through my work originally leading the non-profit organization Surgeons OverSeas, and as Director of Memorial Sloan Kettering’s (MSKs) Global Cancer Disparity Initiative. My research is focused on defining disparities in cancer care, cancer outcomes, surgical oncology training, and introducing new diagnostic tests in sub-Saharan Africa. I co-founded a consortium of investigators in multiple centers in Nigeria (ARGO) centered on cancer research and training, which has created a robust clinical, pathologic, and radiologic database. Prospective studies exploring differences in the biology of CRC and community-based screening projects for CRC have been completed. This consortium is now the center of an NCI UG3/UH3-funded study of a new CRC point-of-care screening test, for which I serve as PI. In 2016, we also expanded our research and training to breast cancer. I am co-investigator and senior faculty on multiple prospective breast cancer screening and diagnostic studies funded by the NIH and the Prevent Cancer Foundation.

Education for trainees and faculty with a focus on cancer in sub-Saharan Africa has also been a priority. I have sponsored cancer training symposia and 3-month observation fellowships for over 15 African physicians at MSKCC, and mentored Nigerian and Kenyan surgical faculty enrolled in the Cornell Masters in Clinical Research. In the US, I initiated the first global cancer surgery fellowship, with a one-year fellowship in New York and Nigeria. I also mentor over 10 MSK faculty members whose careers focus on oncology in Africa. With my work with the Lancet Oncology Global Cancer Surgery Commission, the UICC Global Task Force on Radiotherapy, the AACR, and ARGO, I participate in the global discussion about how LMICs can build the global collaborations and the infrastructure needed to treat cancer patients.

MBChB, MPhil, MMed.
MBChB, MPhil, MMed.Sam M. Mbulaiteye
Education :
1990 MBChB (Medicine and Surgery), Makerere University, Kampala, Uganda
1994 Masters in Philosophy (MPhil) (Epidemiology and Biostatistics), University of Cambridge, Cambridge, UK
1996 Master’s in Medicine (MMed) (Internal Medicine), Makerere University, Kampala, Uganda

Employment history:
1996-1998 Medical Officer Special Grade, Uganda Cancer Institute, & Project Leader, Uganda Kaposi Sarcoma Study Group
1998-2000 Senior Medical Officer, Uganda Virus Research Institute, Entebbe, Uganda, / Project Leader, Medical Research Council Programme on AIDS in Uganda HIV Population Dynamics Study (General Population Cohort)
2005-2013 Tenure-Track Investigator, IIB, DCEG, NCI
2013-present Senior Investigator, IIB, DCEG, NCI

Epidemiology of Burkitt Lymphoma in East Africa (The EMBLEM Study: 2010-2016) (PI) A population-based case-control study ( to investigate the risk factors of paediatric Burkitt lymphoma in East Africa.

Professional Honours and Recognition
2008 National Institutes of Health Award of Merit
2011 NCI Director Principal Investigator Innovation Award to study “Multiple Plasmodium falciparum malaria genotype infection: a link to childhood African Burkitt lymphoma”
2015 NIH Directors Seminar Series: Burkitt lymphoma: a model of polymicrobial carcinogenesis and global oncology

Scientific Leadership and Service
2011-2012 Member, IARC Monograph 104 “Polyoma viruses, BK, SV40, and Malaria”
2013-2019 Member, Burkitt Lymphoma Genome Sequencing Project Steering Committee, NCI Centre for Cancer Genomics

Self-Assessment report:

I am a senior investigator in the Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI). I am internationally re-known for my research work on Burkitt lymphoma (BL), Kaposi sarcoma (KS) and immunosuppression-associated cancers in persons with HIV. I trained as a medical doctor at Makerere University, Kampala (Uganda) where I also specialized in internal medicine (1996). I have an advanced degree in epidemiology from Cambridge University, UK (1994). I have led independent research programs utilizing case-control, population cohort, and registry-linkage methodology in Uganda, Kenya, Tanzania, Nigeria, Ghana, India, the UK, and the US to answer my research questions. I am one of a few Africans to successfully bridge research careers in Africa and at a premier international institution. This began with move to NCI in December 2000 and has bloomed into a comprehensive multi-disciplinary program on BL in the form of the EMBLEM study (, a tumor of enormous significance in many African countries.

I joined AORTIC in 2005 and have attended all AORTIC biennial meetings since. I seek to increase the visibility of AORTIC and to mentor young scientists to be productive. As co-Editor-in-Chief of Infectious Agents and Cancer (IAC) I have advocated for subsidized access to publication opportunities to AORTIC members.

As a tenured Investigator at NCI, I bring a unique perspective to AORTIC. My challenges revolve around inability to develop a strong network of Africans to compete for grants to sustain work initiated in the BL area. This means that the benefits from pilot work are not realized. AORTIC members in North America can help sustain and strengthen technology transfer for the continent. My vision is to see that the number of direct grant funding won by AORTIC members for their Africa-based projects increases as a primary strategy for building capacity and sustainability.